Clinical Investigations
|
|
- Shonda Powers
- 5 years ago
- Views:
Transcription
1 Clinical Investigations Risk Factors of Cardiac Troponin T Elevation in Patients with Stable Coronary Artery Disease After Elective Coronary Drug-Eluting Stent Implantation Zhang-Wei Chen, MD; Ju-Ying Qian, MD; Jian-Ying Ma, MD; Lei Ge, MD; Jun-Bo Ge, MD Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, PR China Address for correspondence: Junbo Ge, MD, FESC, FACC, FSCAI Department of Cardiology Zhongshan Hospital Fudan University Shanghai Institute of Cardiovascular Diseases 180 Fenglin Road Shanghai , PR China Ge.junbo@hotmail.com Background: Cardiac troponin T elevation after coronary intervention has been demonstrated to be associated with the prognosis of coronary artery disease (CAD). However, there were few studies about comprehensive risk factors analysis of troponin T elevation after elective drug-eluting stent (DES) implantation. Hypothesis: The prognosis of CAD after coronary interventions was associated with clinical and procedural risk factors of CAD, such as age, hypertension, severity extent of CAD and so on. Methods: From March to December in 2010, patients with stable CAD were admitted for elective coronary intervention in our hospital. They were divided into an elevated troponin T group and a normal troponin T group by postprocedural troponin T. Clinical factors, laboratory-test factors, and angiographic factors (such as gender, age, cholesterol, Gensini score, and others) were analyzed. Results: A total of 209 patients with an average age of 64.0 ± 9.9 years were enrolled in the study: 70 patients with elevated troponin T ( 0.03 ng/ml) after DES implantation and 139 patients with normal troponin T (<0.03 ng/ml). After univariate analysis, we found that age, hypertension, total cholesterol, low density lipoprotein-cholesterol (LDL-C), Gensini score, number of stenosed vessels, and total implanted stents were associated with postprocedural troponin T elevation. According to the results of multivariate analysis, we found that age, total cholesterol, number of stenosed vessels, and number of implanted stents were independent risk factors of postprocedural troponin T elevation. Conclusions: Age, serum total cholesterol, number of stenosed vessels, and number of implanted stents could be independent risk factors of troponin T elevation after elective DES implantation. Introduction Cardiac troponin T, which is a highly sensitive and specific biomarker for myocardial injury, 1 has been demonstrated to be associated with the prognosis of coronary artery disease (CAD). Several reports have shown that an increase in cardiac troponin T can be found in a proportion of patients after percutaneous coronary intervention (PCI), ranging from less than 10% to almost 50%. 2,3 It has also been reported that elevation of troponin T is relatively common among patients with stable coronary artery disease undergoing PCI and is an independent prognostic indicator of ischemic complications. 4,5 However, there were few studies about comprehensive risk factor analysis of troponin T elevation in patients with stable CAD after drug-eluting stent (DES) implantation. Therefore, we designed this clinical study to Z. Chen and J. Qian contributed equally to the article. This study was supported by grants from the National Natural Science Foundation of China ( and ). The authors have no funding, financial relationships, or conflicts of interest to disclose. 768 comprehensively elaborate the risk factors of troponin T elevation after DES implantation in patients with stable CAD, including clinical factors, laboratory-test factors, and angiographic factors. Methods Study Population and Measurements From March to December in 2010, a total of 209 patients referred to our hospital with stable angina pectoris for elective coronary intervention were enrolled in this study. The inclusion criteria were as follows: (1) patients 18 to 85 years old; (2) providing a complete clinical history; (3) underwent DES implantation; and (4) normal preprocedural troponin T (below the 10% coefficient of variation [CV] value, <0.03 ng/ml) 6 and creatine kinase (CK) muscle and brain subunits (MB) (<23 U/L). The exclusion criteria were as follows: (1) acute coronary syndrome; (2) elevated cardiac troponin T ( 0.03 ng/ml) and CK-MB ( 23 U/L) before coronary intervention; (3) heart failure, cardiomyopathy, congenital heart diseases, and heart valve diseases; (4) treated coronary lesion was chronic total occlusion; (5) recent surgery or trauma; (6) active Received: June 30, 2011 Accepted with revision: August 17, 2011
2 chronic inflammation; (7) dysfunction of hematological and immunological system; or (8) carcinoma or a condition treated with immunosuppressive agents. The study was approved by the local ethics committee and informed consent was obtained from each patient. Measurements and Population Grouping The clinical characteristics of all patients including gender, age, smoking history, primary hypertension, diabetes, and hyperlipidemia were recorded before coronary angiography. Fasting blood samples before and after angiography were drawn to detect blood biochemistry and complete blood-cell counts. Cardiac troponin T was measured before and within 24 hours (from 10 to 20 hours) after coronary intervention. Serum level of troponin T was analyzed by immunoturbidimetry (Hitachi automatic biochemistry analyzer). The upper limit of normal for the assay is <0.03 ng/ml. Patients with postprocedural troponin T 0.03 ng/ml were defined as elevated troponin T group (n = 70) and others were defined as normal troponin T group (n = 139). Coronary Angiography and Intervention Coronary angiography was performed in all patients after admission. The patient was considered as having CAD once obstructive lesion of 50% reduction of lumen diameter existed in at least 1 of the coronary arteries. The severity of coronary artery disease was evaluated by: 1. Number of stenosed vessels: represented as the number of major stenosis in epicardial arteries with at least 1 obstructive lesion ( 50% reduction of lumen diameter), including left anterior descending artery (LAD), left circumflex artery (LCX), right coronary artery (RCA), and left main artery (LM). 2. Gensini score 7 for graded narrowing of the lumen: 1 for 1% to 25%, 2 for 26% to 50%, 4 for 51% to 75%, 8 for 76% to 90%, 16 for 91% to 99%, and 32 for total occlusion. This score is multiplied by a factor accounting for the importance of the lesion position in the coronary arterial tree; eg, 5 for LM, 2.5 for proximal LAD, and 1 for proximal RCA. The severity of disease was expressed as the sum of the scores for individual lesions. Gensini score, number of stenosed vessels, treated vessels, and implanted stents of each enrolled patient were recorded by observers who were blinded to the results of laboratory tests and grouping. In addition, lesion characteristics, such as diffuse lesion, bifurcation lesion and calcified lesion, were also recorded. Statistical Analysis Data were presented as the percentage or mean ± standard deviation (SD). Chi-square analysis was used to compare the frequency for categorical variables, and Student t analysis was used to compare the mean for continuous variables. Correlation analysis (Spearman test) was performed to evaluate the correlations between serum level of postprocedural troponin T and risk factors. Multivariable analysis (logistic) was performed to identify independent risk factors of elevated post-procedural troponin T. Statistical analyses were performed with SPSS software (version 18.0; SPSS Inc., Chicago, IL). All P values were 2-sided, and P < 0.05 was considered statistically significant. Results Demographic Data of Patients A total of 209 patients were enrolled in this study. There were 148 males with an average age of 62.4 ± 9.9 years and 61 females with an average of 68.1 ± 9.0 years. Their clinical characteristics and biochemical profiles were presented in Table 1. Compared with patients in normal troponin T group (n= 139), patients with elevated postprocedural troponin T (n = 70) had higher average age (68.1 vs 62.0 years; P < 0.01) and higher prevalence of hypertension (81.4% vs 61.9%; P < 0.01). In addition, plasma levels of total cholesterol and low density lipoproteincholesterol (LDL-C) were higher in patients with elevated troponin T than those with normal troponin T. Regarding the angiographic and interventional factors, we analyzed the difference concerning Gensini score, number of stenosed vessels, treated vessels, and implanted stents between the patients with and without elevated troponin T, as shown in Table 1. We found that patients with elevated postprocedural troponin T had more severe CAD and underwent more stents implantation. Association Between Postprocedural Troponin T and Risk Factors In order to identify the correlation between serum level of postprocedural troponin T and risk factors (including age, total cholesterol, LDL-C, and Gensini score), the correlation analysis (Spearman test) was performed. It was shown that there were significantly positive correlations between postprocedural troponin T and age (r = 0.336; P < 0.01) and Gensini score (r = 0.368; P < 0.01), shown in Figure 1. However, there were no significant correlations between troponin T and cholesterol. The patients were further classified into 4 subgroups by serum level of postprocedural troponin T: group A, 0.09 ng/ml (triple upper limit of normal troponin T); group B, ng/ml (lower than triple upper limit and higher than normal upper limit); group C, 0.01 to 0.03 ng/ml; and group D, <0.01 ng/ml. We found that there was a significantly higher Gensini score in patients with higher postprocedural troponin T, as shown in Figure 2A. In addition, the number of stenosed vessels was 2.1, 2.3, 1.7, and 1.4 in these 4 groups, respectively. Numbers of treated vessels (1.4 vs 1.3 vs 1.0 vs 1.0) and implanted stents (2.0 vs 1.7 vs 1.4 vs 1.2) in patients with higher troponin T were higher than those with lower level, as shown in Figure 2B. Association Between Postprocedural Troponin T and Angiographic Characteristics Characteristics of angiographic lesion, including diffuse lesion, thrombus present, bifurcation lesion, and calcified lesion, were recorded in our study. According to the results 769
3 Table 1. Comparison of Demographic Data Between Patients with and Without Troponin T Elevation After Elective PCI Clinical factors Elevated Troponin T Group (n = 70) Normal Troponin T Group (n = 139) P Male (%) 47 (67.1%) 101 (72.3%) Age (y) 68.1 ± ± 9.7 <0.01. Hypertension (%) 57 (81.4%) 86 (61.9%) <0.01 Hyperlipidemia (%) 44 (62.9%) 70 (50.4%) Diabetes (%) 20 (28.6%) 27 (19.4%) Smoking (%) 24 (34.3%) 67 (48.2%) Laboratory-test factors Serum creatinine (μmol/l) 76.7 ± ± Serum uric acid (mmol/l) ± ± Fibrinogen (g/l) ± ± Total cholesterol (mmol/l) 4.41 ± ± 0.88 <0.01 Triglyceride (mmol/l) 2.07 ± ± LDL-C (mmol/l) 2.44 ± ± HDL-C (mmol/l) 1.11 ± ± Lipoprotein-a (mmol/l) ± ± Preprocedural CK-MB (U/L) 13.6 ± ± Postprocedural CK-MB (U/L) 17.4 ± ± Preprocedural ctnt (ng/ml) <0.03 ng/ml <0.03 ng/ml Postprocedural ctnt (ng/ml) ± ± <0.01 Angiographic factors Gensini score 37.9 ± ± 15.7 <0.01 Number of stenosed vessels 2.3 ± ± 0.7 <0.01 Number of treated vessels 1.3 ± ± 0.2 <0.01 Number of stent implantation 1.8 ± ± 0.5 <0.01 Abbreviations: CK-MB, creatine kinase-mb; ctnt, cardiac troponin T; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoproteincholesterol; PCI, percutaneous coronary intervention. Bold indicates P is less than of chi-square analysis, we found there was higher prevalence of diffuse lesion (55.7% vs 28.8%; P < 0.01) and bifurcation lesion (20% vs 9.4%; P = 0.028) in patients with elevated postprocedural troponin T than those with normal level, shown in Figure 3. There was no significant difference of prevalence of thrombus present and calcified lesion between 2groups. Multivariate Logistic Regression Analysis for Elevated Postprocedural Troponin T Logistic analysis was used to evaluate the association between postprocedural troponin T and risk factors. In this analysis, postprocedural troponin T elevation was employed as a dependent variable, while age, hypertension, total cholesterol, LDL-C, Gensini score, number of stenosed vessels, and total stents implanted were set as independent variables (Table 2). After adjustment by other associated factors, the risk of postprocedural troponin T elevation was increased 177% and 105% by number of implanted stents and stenosed vessels, respectively. Age (odds ratio [OR] = 1.050; 95% confidence interval [CI], ; P = 0.014) and higher total cholesterol (OR = 2.979; 95% CI, ; P = 0.016) also increased the risk of postprocedural troponin T elevation. Discussion Cardiac troponin T is highly sensitive and specific biomarkers for myocardial injury. 1 In the setting of unstable angina or non-st-segment elevation myocardial infarction (MI), their elevation is associated with more complex coronary 770
4 (A) (B) Figure1. Correlations between postprocedural troponin T level and (A) age and (B) Gensini score. Figure 2. The difference of (A) Gensini score and (B) number of stenosed vessels, treated vessels, and implanted stents in 4 different groups classified by postprocedural troponin T (Group A, 0.09 ng/ml; group B, ng/ml; group C, ng/mL; andgroup D, <0.01 ng/ml). artery stenosis, visible thrombus, plaque rupture, and multivessel CAD. 8,9 Moreover, in the setting of acute coronary syndrome, patients with baseline elevations of troponin T have a higher risk of death or recurrent MI early after presentation, 10,11 after PCI 12 and during long-term follow up. 13 It has also been demonstrated that elevation of troponin T is relatively common among patients with stable CAD undergoing PCI and is an independent prognostic indicator of ischemic complications. 4,5 Prasad et al found that an isolated minor elevation in troponin T after PCI without a rise in CK-MB following PCI provided long-term prognostic information regarding mortality and MI. 6 Several reports have shown that an increase in cardiac troponin T can be found in a proportion of patients after PCI ranging from less than 10% to almost 50%. 2,3 The proportion of elevation of troponin T after PCI in our study was 33.5% (70/209). This supports that cardiac troponin T elevation was quite common after PCI in patients with stable CAD. The mechanisms responsible for cardiac enzyme release after PCI were related to myocardial ischemic injury or necrosis, caused by occlusion due to embolization, 14,15 side branch occlusion due to plaque shifting, 16,17 coronary dissection, 18 coronary spasm, 16 hypotension requiring administration of vasopressors, 19 and prolonged ischemia due to balloon inflations. 20 There were few studies comprehensively elaborating the risk factors of troponin T elevation after PCI in patients with stable CAD. Prasad et al 6 found that patients with elevated postprocedural troponin T underwent more multivessel coronary intervention and had more complicated procedural outcomes, such as coronary artery dissection and branch vessel occlusion. Furthermore, patients with a rise in troponin T were older, more likely to have moderate to severe angina, a history of congestive heart failure, an ejection fraction <40%, and peripheral vascular disease In our study, we analyzed the risk factors of postprocedural troponin T elevation from 3 aspects, including clinical factors (age, gender, history of hypertension, diabetes, and smoking), laboratorytest factors (serum cholesterol, triglyceride, uric acid, and fibrinogen), and angiographic factors (angiographic characteristics, Gensini score, number of stenosed vessels, 771
5 (A) (B) (C) (D) Figure3. The difference of the prevalence of (A) diffuse lesions, (B) bifurcation lesions, (C) calcified lesions, and (D) thrombus present between patients with or without postprocedural troponin T elevation after PCI. Abbreviation: PCI, percutaneous coronary intervention. Table 2. Multivariate Logistic Regression Analysis for Troponin T Elevation in Patients With Stable CAD After Elective PCI r 95% Confidence Intervals Age Hypertension Total cholesterol LDL-C Gensini score Number of stenosed vessels Number of stents implantation Abbreviations: CAD, coronary artery disease; LDL-C, low density lipoprotein-cholesterol; PCI, percutaneous coronary intervention. Bold indicates P is less than and number of implanted stents). According to the univariate and multivariate analysis, we found that age, serum total cholesterol, number of stenosed vessels, and number of stents implanted were independent risk factors of troponin T elevation after elective DES implantation. The relationship between postprocedural cardiac marker elevation and adverse long-term outcome was very intriguing. One possible explanation was that regional myocardial damages occurred or local scar formed in patients with elevated troponin T. 21 Myocardial injury could impair left ventricular function and predispose to arrhythmic events, P which influenced the survival and clinical outcomes. Alternatively, postprocedural troponin T elevation per se could be a biomarker of severe coronary artery disease, vulnerable coronary plaques, 22 or complicated coronary procedure. Our study supported the latter opinion. Older age, higher cholesterol, and higher Gensini score in patients with elevated troponin T implied more severe CAD. The atherosclerotic plaque burden in these patients might be greater than that of younger patients and patients with lower cholesterol levels. Therefore, the incidence of troponin T elevation could be higher after coronary angioplasty and stent implantation. Of course, multivessel stenosed and multistent implantation could also result in more atherosclerotic debris dropping, which impaired or occluded coronary microcirculation. Interestingly, Gensini score was not an independent predictive factor for postprocedural elevated troponin T (OR = 1.014; P = 0.268) after multivariate analysis, although we found a significant difference in Gensini score between 2 groups of patients after univariate analysis. After further analysis, we found that if the factor number of stenosed vessels was excluded from the independent variables, the OR of the Gensini score will reach statistical difference (OR = 1.032; 95% CI, ; P = 0.003). We speculate that there might be an overlapping or similar effect between Gensini score and number of stenosed vessels on troponin T, which influenced the statistical result of the Gensini score. In addition, the small sample size of this study might be another reason. This study had several limitations: (1) small number of patients included; (2) lack of postprocedural echocardiography data for each patient; (3) classical biomarkers 772
6 of inflammation, such as C-reactive protein (CRP), were not routinely detected; and (4) angiographic characteristics were not further measured by intracoronary ultrasound. These limitations will be taken into account in our further clinical research and prospective studies. Conclusion Cardiac troponin T elevation in patients with stable CAD after elective PCI was associated with age, hypertension, cholesterol, Gensini score, diffuse lesion, bifurcation lesion, number of stenosed vessels, and number of implanted stents. This implies that troponin T elevation was linked to the severity of CAD. Age, serum total cholesterol, number of stenosed vessels, and number of implanted stents could be independent risk factors of troponin T elevation in patients with stable CAD after elective DES implantation. References 1. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36: Karim MA, Shinn M, Oskarsson H, et al. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1995;76: Abbas SA, Glazier JJ, Wu AH, et al. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty. Clin Cardiol. 1996;19: Kizer JR, Muttrej MR, Matthai WH, et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J. 2003;24: Jeremias A, Kleiman NS, Nassif D, et al. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Circulation. 2008;118: Prasad A, Singh M, Lerman A, et al. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol. 2006;48: Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51: Lindahl B, Diderholm E, Lagerqvist B, et al. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol. 2001;38: Heeschen C, van Den Brand MJ, Hamm CW, et al. Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation. 1999;100: Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335: Heidenreich PA, Alloggiamento T, Melsop K, et al. The prognostic value of troponin in patients with non-st elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol. 2001;38: Kastrati A, Mehilli J, Neumann FJ, et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA. 2006;295: de Filippi CR, Tocchi M, Parmar RJ, et al. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes. J Am Coll Cardiol. 2000;35: Abdelmeguid AE, Ellis SG, Sapp SK, et al. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J. 1996;131: Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101: Klein LW, Kramer BL, Howard E, et al. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol. 1991;17: Abdelmeguid AE, Whitlow PL, Sapp SK, et al. Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure. Circulation. 1995;91: Kugelmass AD, Cohen CJ, Moscucci M, et al. Elevation of creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol. 1994;74: Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-mb fraction after percutaneous coronary interventions. Circulation. 1996;94: Heyndrickx GR, Amano J, Kenna T, et al. Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. J Am Coll Cardiol. 1985;6: Selvanayagam JB, Porto I, Channon K, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. 2005;111: Mehran R, Dangas G, Mintz GS, et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation. 2000;101:
Myocardial Damage in Successful Single Vessel Coronary Angioplasty as Assessed by Creatinine Kinase and its Myocardium Band Isoenzyme Levels
ORIGINAL ARTICLE Myocardial Damage in Successful Single Vessel Coronary Angioplasty as Assessed by Creatinine Kinase and its Myocardium Band Isoenzyme Levels Shahid Abbas, Farhan Tayyab, Naseer Ahmed Samor,
More informationImpact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease
Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,
More informationPeriprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion
Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol
More informationCulprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome
Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,
More informationEffect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
More informationPercutaneous Coronary Interventions Without On-site Cardiac Surgery
Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European
More informationP ostprocedural creatine kinase and its MB isoform
1181 INTERVENTIONAL CARDIOLOGY AND SURGERY Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease T Nageh, R A Sherwood, B M Harris, M R Thomas... See
More informationDeclaration of conflict of interest. Nothing to disclose
Declaration of conflict of interest Nothing to disclose Hong-Seok Lim, Seung-Jea Tahk, Hyoung-Mo Yang, Jin-Woo Kim, Kyoung- Woo Seo, Byoung-Joo Choi, So-Yeon Choi, Myeong-Ho Yoon, Gyo-Seung Hwang, Joon-Han
More informationAbstract Background: Methods: Results: Conclusions:
Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li
More informationUPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18
UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment
More informationMortality Risk Conferred by Small Elevations of Creatine Kinase-MB Isoenzyme After Percutaneous Coronary Intervention
Journal of the American College of Cardiology Vol. 42, No. 8, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)01044-1
More informationLM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
More informationImaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD
Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference
More informationContemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease
Contemporary Percutaneous Coronary Intervention Versus Balloon Angioplasty for Multivessel Coronary Artery Disease A Comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the
More informationJournal of the American College of Cardiology Vol. 38, No. 3, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 3, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01423-1 Effect
More informationValidation of a Novel Clinical Prediction Score for Severe Coronary Artery Diseases before Elective Coronary Angiography
Validation of a Novel Clinical Prediction Score for Severe Coronary Artery Diseases before Elective Coronary Angiography Zhang-Wei Chen 1., Ying-Hua Chen 2., Ju-Ying Qian 1 *, Jian-Ying Ma 1, Jun-Bo Ge
More informationCoronary Artery Disease: Revascularization (Teacher s Guide)
Stephanie Chan, M.D. Updated 3/15/13 2008-2013, SCVMC (40 minutes) I. Objectives Coronary Artery Disease: Revascularization (Teacher s Guide) To review the evidence on whether percutaneous coronary intervention
More informationCardiac Troponin I Levels and Clinical Outcomes in Patients With Acute Coronary Syndromes The Potential Role of Early Percutaneous Revascularization
Journal of the American College of Cardiology Vol. 34, No. 6, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00434-9 Cardiac
More informationElevations in Troponin T and I Are Associated With Abnormal Tissue Level Perfusion. A TACTICS-TIMI 18 Substudy
Elevations in Troponin T and I Are Associated With Abnormal Tissue Level Perfusion A TACTICS-TIMI 18 Substudy Graham C. Wong, MD; David A. Morrow, MD, MPH; Sabina Murphy, MPH; Nicole Kraimer, MS; Rupal
More informationARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) trial
ARMYDA-RECAPTURE ( for Reduction of MYocardial Damage during Angioplasty) trial Prospective, multicenter, randomized, double blind trial investigating efficacy of atorvastatin reload in patients on chronic
More informationPROMUS Element Experience In AMC
Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical
More informationFinal Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)
The Microport FIREBIRD Polymer-based Sirolimus- Eluting Stent Clinical Trial Program Update: The FIC and FIREMAN Registries Junbo Ge, MD, FACC, FESC, FSCAI On behalf of Runlin Gao (FIC PI) and Haichang
More informationFormation of and countermeasures for subacute coronary stent thrombosis in elderly diabetic patients
Formation of and countermeasures for subacute coronary stent thrombosis in elderly diabetic patients Z.-F. Li 1, Y.-P. Zhang 2, Z.-Q. Qin 2, X.-L. Li 1, C.-H. Gao 1, S. Yang 1 and Z.-J. Chen 1 1 Department
More informationStatin pretreatment and presentation patterns in patients with acute coronary syndromes
Brief Report Page 1 of 5 Statin pretreatment and presentation patterns in patients with acute coronary syndromes Marcelo Trivi, Ruth Henquin, Juan Costabel, Diego Conde Cardiovascular Institute of Buenos
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationPrognostic importance of troponin T and creatine kinase after elective angioplasty
International Journal of Cardiology 120 (2007) 242 247 www.elsevier.com/locate/ijcard Prognostic importance of troponin T and creatine kinase after elective angioplasty Mark B. Nienhuis a, Jan Paul Ottervanger
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationWhat oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor
76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class
More informationClopidogrel Date: 15 July 2008
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinicalTrials.gov
More informationCase Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?
Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized
More informationASSOCIATION BETWEEN QUANTITATIVE TROPONIN T LEVELS AND ANGIOGRAPHIC FINDINGS IN UNSTABLE ANGINA AND NON ST ELEVATION MYOCARDIAL INFARCTION
ASSOCIATION BETWEEN QUANTITATIVE TROPONIN T LEVELS AND ANGIOGRAPHIC FINDINGS IN UNSTABLE ANGINA AND NON ST ELEVATION MYOCARDIAL INFARCTION 1 1 2 Shaukat Ali, Syed Faiz ul Hassan Rizvi, Nadeem Hayat Mallick
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationInfluence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study
Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01476-0 Influence
More informationIn-Ho Chae. Seoul National University College of Medicine
The Earlier, The Better: Quantum Progress in ACS In-Ho Chae Seoul National University College of Medicine Quantum Leap in Statin Landmark Trials in ACS patients Randomized Controlled Studies of Lipid-Lowering
More informationResults of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies
Intracoronary Radiation Therapy Improves the Clinical and Angiographic Outcomes of Diffuse In-Stent Restenotic Lesions Results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions
More informationMeasuring Natriuretic Peptides in Acute Coronary Syndromes
Measuring Natriuretic Peptides in Acute Coronary Syndromes Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Consultant Cardiologist Chief Academic and Scientific Officer St. John Providence Health
More informationIschemic heart disease
Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery
More informationIn patients with acute coronary syndromes, the elevation. Prognostic Value of Troponin T after Elective Percutaneous Coronary Intervention
Original Article rognostic Value of Troponin T after Elective ercutaneous Coronary Intervention A Ghaemian 1, S Masoumi 1, RA Mohammadpour 2 1 Mazandaran Heart Center, 2 Department of Biostatistics, Mazandaran
More informationEXPERIMENTAL AND THERAPEUTIC MEDICINE 6: , 2013
840 Identification of independent risk factors for restenosis following bare metal stent implantation: Role of bare metal stents in the era of drug eluting stents CHANG BUM PARK 1 and HOON KI PARK 2 1
More informationSerum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease
Serum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease MAK Akanda 1, KN Choudhury 2, MZ Ali 1, MK Kabir 3, LN Begum 4, LA Sayami 1 1 National Institute of Cardiovascular
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationIncremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary Intervention
Incremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary Intervention Derek P. Chew, MBBS; Deepak L. Bhatt, MD; Mark A. Robbins, MD;
More informationReeju Manandhar, Chaofeng Sun. Original article
Original article Association of different blood parameters with the early patency of Infarct related artery in ST elevation Myocardial Infarction, a comparative analysis. Reeju Manandhar, Chaofeng Sun
More informationAcute Myocardial Infarction
Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:
More informationJournal of the American College of Cardiology Vol. 42, No. 10, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 42, No. 10, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.05.007
More informationFFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria
FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria I would like to express my personal gratitude to Dr. BK Koo for opening
More information2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center
2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular
More informationJournal of the American College of Cardiology Vol. 40, No. 6, by the American College of Cardiology Foundation ISSN /02/$22.
Journal of the American College of Cardiology Vol. 40, No. 6, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)02119-8
More informationAcute Myocardial Infarction. Willis E. Godin D.O., FACC
Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable
More informationPredictors of 6-Month Angiographic Restenosis inside Bare-Metal Stent in Chinese Patients with Coronary Artery Disease
Original Article Acta Cardiol Sin 2009;25:1 6 Coronary Artery Disease Predictors of 6-Month Angiographic Restenosis inside Bare-Metal Stent in Chinese Patients with Coronary Artery Disease Yung-Lung Chen,
More informationCardiovascular Research Foundation and Columbia University Medical Center, New York.
Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,
More informationPatient referral for elective coronary angiography: challenging the current strategy
Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology
More informationCoronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy
Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy Takayuki Ohno, MD, Shinichi Takamoto, MD, Noboru Motomura, MD, Minoru Ono,
More informationGender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic
Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) J. D. Abbott, et al. Am J Cardiol (2007) 99;626-31
More informationPrognostic Value of C-Reactive Protein and Troponin T Level in Patients With Unstable Angina Pectoris C T KASANUKI, MD, FJCC
C T Prognostic Value of C-Reactive Protein and Troponin T Level in Patients With Unstable Angina Pectoris Hiroyuki Yukio Hiroshi TANAKA, MD TSURUMI, MD KASANUKI, MD, FJCC Abstract Objectives. The prognosis
More informationJ. Schwitter, MD, FESC Section of Cardiology
J. Schwitter, MD, FESC Section of Cardiology CMR Center of the CHUV University Hospital Lausanne - CHUV Switzerland Centre de RM Cardiaque J. Schwitter, MD, FESC Section of Cardiology CMR Center of the
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationTCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI
Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi
More informationPrognostic Significance of Epicardial Blood Flow Before and After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes
Journal of the American College of Cardiology Vol. 52, No. 7, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.05.009
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More informationPercutaneous Intervention of Unprotected Left Main Disease
Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected
More informationDisclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None
Inpatient Management of Non-ST Elevation Acute Coronary Syndromes Edward McNulty MD, FACC Assistant Clinical Professor UCSF Director, SF VAMC Cardiac Catheterization Laboratory Disclosures None New Guidelines
More informationAngiographic and Intravascular Ultrasound Predictors of In-Stent Restenosis
1630 JACC Vol. 32, No. 6 Angiographic and Intravascular Ultrasound Predictors of In-Stent Restenosis SHUNJI KASAOKA, MD, JONATHAN M. TOBIS, MD, FACC, TATSURO AKIYAMA, MD,* BERNHARD REIMERS, MD,* CARLO
More informationPost Operative Troponin Leak: David Smyth Christchurch New Zealand
Post Operative Troponin Leak: Does It Really Matter? David Smyth Christchurch New Zealand Life Was Simple Once Transmural Infarction Subendocardial Infarction But the Blood Tests Were n t Perfect Creatine
More informationRafał Wolny, Jerzy Pręgowski, Paweł Bekta, Zbigniew Chmielak, Adam Witkowski
Case report Early occlusion of the non-infarct-related coronary artery following successful primary percutaneous coronary intervention in ST-elevation myocardial infarction Rafał Wolny, Jerzy Pręgowski,
More informationClinical Investigations
Clinical Investigations Clinical Outcomes for Single Stent and Multiple Stents in Contemporary Practice Qiao Shu Bin, MD; Liu Sheng Wen, MD; Xu Bo, BS; Chen Jue, MD; Liu Hai Bo, MD; Yang Yue Jin, MD; Chen
More informationFFR in Multivessel Disease
FFR in Multivessel Disease April, 26 2013 Coronary Physiology in the Catheterization Laboratory Location: European Heart House, Nice, France Pim A.L. Tonino, MD, PhD Hartcentrum, Eindhoven, the Netherlands
More informationRichard Grocott Mason
Richard Grocott Mason What to do with a 50 year old man with chest pain? Does the pain sound cardiac? Is this a possible acute coronary syndrome? Does patient have a previous cardiac history? Natural history
More informationCoronary Plaque Sealing: The DEFER Study and more...
Coronary Plaque Sealing: The DEFER Study and more... How Waiting Can Be Beneficial in Stable Coronary Artery Disease Patients ESC, Stockholm, 2005 M. Romanens, 21.09.2005 at www.kardiolab.ch DEFER Study:
More informationStatistical analysis plan
Statistical analysis plan Prepared and approved for the BIOMArCS 2 glucose trial by Prof. Dr. Eric Boersma Dr. Victor Umans Dr. Jan Hein Cornel Maarten de Mulder Statistical analysis plan - BIOMArCS 2
More informationFFR-guided Jailed Side Branch Intervention
FFR-guided Jailed Side Branch Intervention - Pressure wire in Bifurcation lesions - Bon-Kwon Koo, MD, PhD Seoul National University Hospital, Seoul, Korea Bifurcation Lesions Bifurcation Lesions Still
More informationCardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
More informationCardiovascular risk and therapeutic benefit of coronary interventions for patients with unstable angina according to the troponin T status
European Heart Journal (2000) 21, 1159 1166 doi:10.1053/euhj.1999.1986, available online at http://www.idealibrary.com on Cardiovascular risk and therapeutic benefit of coronary interventions for patients
More information12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2
Coronary Artery Pathophysiology ACS / AMI LeRoy E. Rabbani, MD Director, Cardiac Inpatient Services Director, Cardiac Intensive Care Unit Professor of Clinical Medicine Major Determinants of Myocardial
More informationClinical Outcomes After Detection of Elevated Cardiac Enzymes in Patients Undergoing Percutaneous Intervention
88 JACC Vol. 33, No. 1 Clinical Outcomes After Detection of Elevated Cardiac Enzymes in Patients Undergoing Percutaneous Intervention BARBARA E. TARDIFF, MD, ROBERT M. CALIFF, MD, FACC, JAMES E. TCHENG,
More informationDepartment of Rheumatology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, P.R. China 2
European Review for Medical and Pharmacological Sciences 2016; 20: 4294-4298 Study on the levels of uric acid and high-sensitivity C-reactive protein in ACS patients and their relationships with the extent
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More information1. Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study Hsieh, B.P., et al. Am
More informationIntracoronary Serum Smooth Muscle Myosin Heavy Chain Levels Following PTCA may Predict Restenosis
Clinical Studies Intracoronary Serum Smooth Muscle Myosin Heavy Chain Levels Following PTCA may Predict Restenosis Yasuhiro TSUCHIO,MD,ShigetoNAITO, MD, Akihiko NOGAMI,MD, Hiroshi HOSHIZAKI, MD, ShigeruOSHIMA,
More information12 Lead EKG Chapter 4 Worksheet
Match the following using the word bank. 1. A form of arteriosclerosis in which the thickening and hardening of the vessels walls are caused by an accumulation of fatty deposits in the innermost lining
More informationEBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb
EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb A. Medina Servicio de Cardiología Hospital Universitario de Gran Canaria Dr. Negrín Islas Canarias (Spain) Provisional
More informationModeling and Risk Prediction in the Current Era of Interventional Cardiology
Modeling and Risk Prediction in the Current Era of Interventional Cardiology A Report From the National Heart, Lung, and Blood Institute Dynamic Registry David R. Holmes, MD; Faith Selzer, PhD; Janet M.
More informationAPPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
More informationBetween Coronary Angiography and Fractional Flow Reserve
Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, MD., PhD. University of Ulsan, College of Medicine Asan Medical Center, Seoul, Korea Visual - Functional
More informationISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions
Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main
More informationTopic. Updates on Definition of Myocardial Infarction
Topic Updates on Definition of Myocardial Infarction In the past, general consensus for MI? Definition of MI by WHO - Combination of 2 of 3 characteristics - 1. Typical Symptoms 2. Enzyme Rise 3. Typical
More informationOverall Changes of the Universal Myocardial Infarction Definition
Overall Changes of the Universal Myocardial Infarction Definition Professor Kristian Thygesen, FESC, FACC, FAHA Aarhus University Hospital, Aarhus, DK Co-Chairman of The Global MI Task Force Declaration
More informationCreatine kinase-mb elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes
European Heart Journal (2004) 25, 313 321 Clinical research Creatine kinase-mb elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes M.T.
More informationNew Insight about FFR and IVUS MLA
New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR
More informationAcute Coronary Syndrome. Sonny Achtchi, DO
Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification
More informationChapter 3. Departments of a Cardiology and b Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands; c
Chapter 3 Incidence, patient s characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatment
More informationIntravascular ultrasound-based analysis of factors affecting minimum lumen area in coronary artery intermediate lesions
Journal of Geriatric Cardiology (2016) 13: 169 174 2016 JGC All rights reserved; www.jgc301.com Research Article Open Access Intravascular ultrasound-based analysis of factors affecting minimum lumen area
More informationNo-reflow is defined as a failure to restore antegrade normal coronary flow despite appropriate treatment of coronary obstruction. The prevalence of t
No reflow in ACS: Treatment strategies and Developments Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology, Peking University People s Hospital No-reflow is defined
More informationBenefit of Performing PCI Based on FFR
Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided
More informationThe Universal Definition of Myocardial Infarction 3 rd revision, 2012
The Universal Definition of Myocardial Infarction 3 rd revision, 2012 Joseph S. Alpert, MD Professor of Medicine, University of Arizona College of Medicine, Tucson, AZ; Editor-in-Chief, American Journal
More informationEssam Mahfouz, MD. Professor of Cardiology, Mansoura University
By Essam Mahfouz, MD. Professor of Cardiology, Mansoura University Agenda Definitions Classifications Epidemiology Risk stratification What is new? What is MI? Myocardial infarction is the death of part
More informationConflict of interest :None. Meta-analysis. Zhangwei Chen, MD
Meta-analysis Addition of Cilostazol to Conventional Dual Antiplatelet Therapy Reduces the Risk of Cardiac Events and Restenosis after Drug-Eluting Stent Implantation Zhangwei Chen, MD Department of Cardiology,
More informationClinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
Aging Research Volume 2013, Article ID 471026, 4 pages http://dx.doi.org/10.1155/2013/471026 Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at
More informationCafri C; Zahger D; Rosenshtein G, Kleshian I; Ilia R
Primary Percutaneous Coronary Intervention and Large Thrombus Burden Lesio: A Questionable Impact of Mesh Covered Stent on the Frequency of No Reflow Cafri C; Zahger D; Rosehtein G, Kleshian I; Ilia R
More information